Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacological evaluation of antinociceptive and anti-inflammatory activities of LQFM202: a new piperazine derivative.
Martins AN, de Souza Almeida D, Florentino IF, da Silva Moreira LK, Turones LC, Batista DC, Machado LS, Vaz BG, Lião LM, de Almeida Ribeiro Oliveira G, Martins JLR, Fajemiroye JO, Menegatti R, Costa EA, da Silva DPB. Martins AN, et al. Among authors: da silva dpb. Inflammopharmacology. 2023 Feb;31(1):411-422. doi: 10.1007/s10787-022-01103-x. Epub 2022 Nov 29. Inflammopharmacology. 2023. PMID: 36443517
Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization.
da Silva DPB, Florentino IF, da Silva DM, Lino RC, Cardoso CS, Moreira LKS, Vasconcelos GA, Vinhal DC, Cardoso ACD, Villavicencio B, Verli H, Vaz BG, Lião LM, da Cunha LC, Menegatti R, Costa EA. da Silva DPB, et al. Inflammopharmacology. 2018 Oct;26(5):1189-1206. doi: 10.1007/s10787-018-0516-7. Epub 2018 Jul 23. Inflammopharmacology. 2018. PMID: 30039481
Anti-inflammatory and antinociceptive activity profile of a new lead compound - LQFM219.
Galvão GM, Florentino IF, Sanz G, Vaz BG, Lião LM, Sabino JR, Cardoso CS, da Silva DPB, Costa EA, Silva ALP, da Silva ACG, Valadares MC, Leite JA, de S Gil E, Menegatti R. Galvão GM, et al. Among authors: da silva dpb. Int Immunopharmacol. 2020 Nov;88:106893. doi: 10.1016/j.intimp.2020.106893. Epub 2020 Sep 3. Int Immunopharmacol. 2020. PMID: 32892073
Anti-inflammatory and antinociceptive effects of LQFM275 - A new multi-target drug.
Turones LC, da Silva DPB, Florentino IF, Martins AN, Almeida DS, Moreira LKDS, Silva MMO, Machado LS, Oliveira GAR, Lião LM, Dos Santos FCA, Pavicic MF, Ehrenfeld P, Menegatti R, Costa EA, Fajemiroye JO. Turones LC, et al. Among authors: da silva dpb. Int Immunopharmacol. 2025 Jan 27;146:113901. doi: 10.1016/j.intimp.2024.113901. Epub 2024 Dec 22. Int Immunopharmacol. 2025. PMID: 39718057
Potential antidepressant-like effect of piperazine derivative LQFM212 in mice: Role of monoaminergic pathway and brain-derived neurotrophic factor.
Moreira LKDS, de Brito AF, da Silva DM, Siqueira L, da Silva DPB, Cardoso CS, Florentino IF, de Carvalho PMG, Ghedini PC, Menegatti R, Costa EA. Moreira LKDS, et al. Among authors: da silva dpb. Behav Brain Res. 2021 Mar 5;401:113066. doi: 10.1016/j.bbr.2020.113066. Epub 2020 Dec 14. Behav Brain Res. 2021. PMID: 33333109
Tert-butyl 4-((1-phenyl-1H-pyrazol-4-yl) methyl) piperazine-1-carboxylate (LQFM104)- New piperazine derivative with antianxiety and antidepressant-like effects: Putative role of serotonergic system.
da Silva DM, Sanz G, Vaz BG, de Carvalho FS, Lião LM, de Oliveira DR, Moreira LKDS, Cardoso CS, de Brito AF, da Silva DPB, da Rocha FF, Santana IGC, Galdino PM, Costa EA, Menegatti R. da Silva DM, et al. Among authors: da silva dpb. Biomed Pharmacother. 2018 Jul;103:546-552. doi: 10.1016/j.biopha.2018.04.077. Epub 2018 Apr 24. Biomed Pharmacother. 2018. PMID: 29677541
Monoamine Involvement in the Antidepressant-Like Effect of β-Caryophyllene.
de Oliveira DR, da Silva DM, Florentino IF, de Brito AF, Fajemiroye JO, da Silva DPB, da Rocha FF, Costa EA, Galdino PM. de Oliveira DR, et al. Among authors: da silva dpb. CNS Neurol Disord Drug Targets. 2018;17(4):309-320. doi: 10.2174/1871527317666180420150249. CNS Neurol Disord Drug Targets. 2018. PMID: 29676236
13 results